Corpus ID: 157773396

Nutrigenomics and Public Engagement An "upstream" inquiry

  title={Nutrigenomics and Public Engagement An "upstream" inquiry},
  author={Joanna Goven and Jack A. Heinemann},
Biopharming in New Zealand: Risk and Governance Implications


Considerations for the successful development and launch of personalised nutrigenomic foods.
  • K. Sutton
  • Business, Medicine
  • Mutation research
  • 2007
How personalised, nutrigenomic foods might be developed and early results from research into food fractions that have the potential to ameliorate Crohn's disease are presented. Expand
Nutrigenomics and the New Zealand food industry
  • Food New Zealand, April.
  • 2004
Getting Personal: Shifting Responsibility for Dietary Health
  • Brighton, UK: Food Ethics Council.
  • 2005
A critical appraisal of the scientific basis of commercial genomic profiles used to assess health risks and personalize health interventions.
There is insufficient scientific evidence to conclude that genomic profiles are useful in measuring genetic risk for common diseases or in developing personalized diet and lifestyle recommendations for disease prevention. Expand
Animal Biopharming in New Zealand Drivers, Scenarios and Practical Implications
Constructive Conversations/Korero Whakaaetanga (Phase 2): Biopharming, Risk Assessment and Regulation. Research Report no.12.
Evidence and Evaluation: Building Public Trust in Genetic Tests for Common Diseases. Research Report, PHG Foundation and Peninsula Medical School
  • 2008
Genetic tests for common diseases: new insights, old concerns
The clinical utility of newly identified genetic variants associated with common diseases needs evaluation and new approaches are needed to evaluate their clinical utility. Expand
Genome health nutrigenomics and nutrigenetics--diagnosis and nutritional treatment of genome damage on an individual basis.
  • M. Fenech
  • Biology, Medicine
  • Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
  • 2008
Development of dietary patterns, functional foods and supplements that are designed to improve genome health maintenance in humans with specific genetic backgrounds may provide an important contribution to a new optimum health strategy based on the diagnosis and individualised nutritional treatment of genome instability i.e. Genome Health Clinics. Expand
Genome-based prediction of common diseases: advances and prospects.
It is argued that new gene discoveries may not evidently improve the prediction of common diseases to a degree that it will change the management of individuals at increased risk. Expand
Genomic profiles for disease risk: predictive or premature?
The unregulated and unvalidated introduction of genomic self-testing may undermine physicians’ efforts to secure public confidence and acceptance of this vital component of “personalized” medicine. Expand